As of September 10, 2024, the Food and Drug Administration (FDA) requires that all mammogram reports sent to patients must include breast density, which should be described as either “not dense” or “dense.” Dense tissue makes it harder to find breast cancer on a mammogram and also raises the risk of developing breast cancer.
In this reel, oncologist Danielle Heller, MD, breast surgical oncologist at the Hartford HealthCare Cancer Institute at St. Vincent’s, explains the importance of recognizing breast density.
